Skip to content
COA & Batch Documentation Available Explore Research Peptides
Research Grade Independently Tested

MOTS-c

Verified Synthesis Batch COA Available
≥ 99% (HPLC) CAS 1627580-64-6 C₁₀₁H₁₅₂N₂₈O₂₂S₂
$79.99 AUD · GST incl.
Select size
  • Certificate of Analysis available for every batch
  • Form: Lyophilised Powder
  • Storage: 2°C-8°C (Refrigerated)
  • Australia-wide, discreet tracked dispatch
  • Research Use Only - not for human or veterinary use

The MOTS-c peptide represents one of the mitochondrial-derived peptides currently becoming popular targets for investigation in fields of metabolism, cellular energy and aging studies. One of the differences between MOTS-c peptide and other peptides which usually have their coding sequences in the nuclear genome is that MOTS-c peptide sequence appears in a small open reading frame of mitochondrial DNA.

Currently, MOTS-c 10mg and MOTS-c 20mg peptides are available for scientific investigation of the processes associated with cellular energy regulation, glucose metabolism, metabolic homeostasis, adaptation to stress and interaction between mitochondria and the cell nucleus.

There is increased scientific interest in MOTS-c peptide research since the discovery that mitochondria are more than just energy generators; they can act as active signaling centers. The ongoing studies are aimed at exploring the role of mitochondrial-derived peptides in metabolic regulation and age-related physiological changes.

What Is MOTS-c?

The name “MOTS-c” stands for “Mitochondrial Open Reading Frame of the 12S rRNA Type-c”. This endogenously produced mitochondrial-derived peptide comprises 16 amino acids and is encoded by the mitochondrial 12S rRNA region. Initially identified as an active metabolically involved signaling molecule.

According to the existing research, MOTS-c can serve as a signaling molecule that communicates between mitochondria and the cell nucleus. In conditions of certain metabolic stresses, MOTS-c is seen to migrate into the nucleus and affect stress response gene expression. The relation of MOTS-c to the processes of metabolic homeostasis, glucose uptake, and cell adaptation are also described in research review articles.

The MOTS-c peptide is mainly studied in the following experimental models:

  • mitochondrial signaling and function;
  • AMPK signaling pathways;
  • glucose uptake and insulin sensitivity models;
  • skeletal muscle metabolism;
  • cellular stress adaptation;
  • metabolic flexibility;
  • exercise physiology;
  • oxidative stress;
  • aging metabolism.

This research field is still actively studied, and results obtained from cell culture and animal experiments do not necessarily imply any clinical outcome yet.

Why Is MOTS-c Being Studied?

The reason MOTS-c is under investigation is that it plays an intermediary role between mitochondrial function and overall cell metabolic signaling. Scientists are interested in the ways that mitochondria transmit information about energy state and metabolic stress in cells.

Metabolic homeostasis is one of the major directions of MOTS-c research. Experiments were performed on the connection of MOTS-c and such processes as glucose uptake, lipid metabolism, insulin sensitivity and skeletal muscle function. Reviews of scientific literature describe associations between the MOTS-c signaling pathway and several other metabolic regulatory pathways.

Exercise and stress adaptation is another direction of MOTS-c research. Scientific studies described the ability of exercise to affect endogenous levels of MOTS-c and experiments with MOTS-c administration during exercise and their influence on animal physical performance and metabolic adaptation.

Also, MOTS-c research is related to mitochondrial aging, cell resilience, oxidative stress and metabolism alterations associated with age. This direction is of scientific interest, but still needs more experimental research in humans.

How Does MOTS-c Work?

The mechanism of action of the suggested MOTS-c consists of different metabolic pathways. The pathway which is studied the most is the connection between MOTS-c and AMP-activated protein kinase which is also called AMPK.

It is worth mentioning that AMPK works as an energy sensor. As shown by experiments, MOTS-c can change folate methionine cycle and purine biosynthesis resulting in the increase of AICAR - one of the most effective AMPK activators. This pathway is being studied for the possible connection with glucose utilisation by cells.

According to researches, MOTS-c can enter the nucleus in case of metabolism stress and affect gene regulation in the nucleus. This mitochondrial to nuclear communication which is discussed in the retrograde signalling theory is one of the main topics of current mitochondrial peptides research.

At the moment the mechanism of MOTS-c still remains to be investigated. Different effects can depend on various factors such as tissue type, experimental model, concentration and metabolic state.

Understanding MOTS-c Dosage

The term MOTS-c dose is frequently sought after in internet searches, however, the research amounts cannot be taken to mean any standardized dosages for treatment. MOTS-c is still an experimental peptide, and there is no standard dosing schedule used in general medical applications.

When it comes to lab research, the type of experimental procedure can differ widely depending on the model being used. The cell culture experiments can make use of concentration-based schedules, while animal testing might determine the amount using body weight and the purpose of the experiment.

The terms MOTS-c 10mg and MOTS-c 20mg indicate the amount of material included in the vial, and they are not dosage, administration schedules or protocols.

It is up to the researcher to determine the protocols by considering scientific procedures and goals.

MOTS-c and Research Quality

The reliability of research done on MOTS-c is highly influenced by the quality of the material used and how well characterised it is. Such things as peptide identity, purity and conditions of storage and shipment can influence reproducibility of experiments.

In the case of MOTS-c peptide for research use, it would be necessary to have analytical information like HPLC purity test, mass spectrometry confirmation of identity and Certificate of Analysis for batches when available.

For research quality assessment it is recommended to pay attention to the following factors:

  • peptide sequence and molecular identity;
  • purity specification;
  • batch/lot identification;
  • analytical testing;
  • conditions of storage/shipping;
  • traceability of documentation;
  • supplier transparency.

Purity percentage does not give the whole picture of quality of research material.

MOTS-c in Australia

The interest in MOTS-c Australia study is part of the general scientific interest in mitochondrial peptides, metabolism and cell aging. Scientific institutions and private labs involved in studies in molecular biology and metabolic science in Australia could be expected to come across MOTS-c through the scientific literature.

It is important to consider the regulation of peptides in Australia. The Therapeutic Goods Administration says that peptide products which have been promoted for therapeutic use will be considered to be therapeutic goods and has recently stepped up efforts to ensure compliance with regulations relating to unapproved peptide products.

This means that research material must be represented properly and not be used with any promotional claims about therapies.

What to Consider Before You Buy MOTS-c

Before purchasing MOTS-c peptide in Australia for scientific research purposes, consider factors other than just price or vial size. Reproducibility of research is determined by the quality of materials used, information provided and correct handling of materials. Pay attention to information such as MOTS-c 10mg or MOTS-c 20mg dosage, batch number, information about analysis performed, storage instructions and information about the supplier’s contact details. You should also verify that the Certificate of Analysis relates specifically to the particular batch purchased.

Watch out for false claims of scientific results turned into claimed benefits for humans. MOTS-c research is currently still very much based on preclinical studies, mechanistic research and early human evidence.

Safety and Current Research

MOTS-c is still a pre-clinical research molecule. While in vitro research has raised interest in the functioning of mitochondria, metabolism and its signaling, adaptation to exercise, and ageing physiology, there is no current evidence for the use of MOTS-c as an approved therapeutic intervention.

The current state of research is still investigating AMPK signaling, regulation of genes in the nucleus, metabolism of muscle tissue, mitochondrial bioenergetics, and metabolic stress. The recent research is still investigating interactions between MOTS-c, AMPK and mitochondria.

One should take into account the type of the study model and the quality of the evidence when evaluating results. In vitro and animal evidence cannot be extrapolated to humans.

Frequently Asked Questions

MOTS-c is a 16-amino-acid mitochondrial-derived peptide encoded within mitochondrial DNA and studied for its role in metabolic and cellular stress signalling.

MOTS-c stands for Mitochondrial Open Reading Frame of the 12S rRNA Type-c.

The difference is the total quantity of peptide material in the vial. These quantities do not represent recommended human doses.

Researchers study MOTS-c in relation to mitochondrial communication, AMPK signalling, glucose metabolism, skeletal muscle biology and stress adaptation.

Experimental research suggests that MOTS-c interacts with metabolic pathways associated with AMPK activation, although the complete mechanism remains under investigation.

Yes. MOTS-c belongs to the group of mitochondrial-derived peptides encoded by short open reading frames in mitochondrial DNA.

There is no universally established general therapeutic dosage. Research protocols vary according to experimental design and study model.

Researchers should evaluate identity testing, HPLC purity data, mass spectrometry results, batch traceability, storage conditions and analytical documentation.

Major areas include metabolic homeostasis, mitochondrial signalling, AMPK pathways, exercise adaptation, glucose metabolism and age-related cellular biology.

No. Findings from cell and animal studies require careful interpretation and further controlled human research before clinical conclusions can be established.

Notice

MOTS-c is an investigational peptide intended for scientific research purposes. It should not be presented as an approved therapeutic medicine in Australia. Researchers and organisations should verify the current regulatory requirements applicable to their intended research, importation, possession and supply activities.

Disclaimer

This content is provided for educational, scientific and research-information purposes only. It does not provide medical advice, treatment recommendations or personal dosage instructions. Available evidence concerning MOTS-c includes preclinical research and ongoing or completed clinical investigations. Further research is required to better understand its safety, pharmacology and potential efficacy for specific research applications.

References

5 sources
  1. Lee C, Zeng J, Drew BG, et al.
    The Mitochondrial-Derived Peptide MOTS-c Promotes Metabolic Homeostasis and Reduces Obesity and Insulin Resistance.
    Cell Metabolism. 2015;21(3):443-454.
    PubMed: https://pubmed.ncbi.nlm.nih.gov/25738459/
  2. Reynolds JC, Lai RW, Woodhead JST, et al.
    MOTS-c Is an Exercise-Induced Mitochondrial-Encoded Regulator of Age-Dependent Physical Decline and Muscle Homeostasis.
    Nature Communications. 2021;12:470.
    PubMed: https://pubmed.ncbi.nlm.nih.gov/33473109/
    Full Text: https://pmc.ncbi.nlm.nih.gov/articles/PMC7817689/
  3. Lee C, Kim KH, Cohen P.
    MOTS-c: A Novel Mitochondrial-Derived Peptide Regulating Muscle and Fat Metabolism.
    Free Radical Biology and Medicine. 2016;100:182-187.
    PubMed: https://pubmed.ncbi.nlm.nih.gov/27216708/
  4. Wan W, Zhang L, Lin Y, Rao X, Wang X.
    Mitochondria-Derived Peptide MOTS-c: Effects and Mechanisms Related to Stress, Metabolism and Aging.
    Journal of Translational Medicine. 2023;21:36.
    Full Text: https://pmc.ncbi.nlm.nih.gov/articles/PMC9854231/
  5. Australian Government, Therapeutic Goods Administration (TGA).
    Concerns Regarding the Public Health Risks Associated with Unapproved Peptide Products.
    Therapeutic Goods Administration. 2026.
    TGA: https://www.tga.gov.au/news/media-releases/concerns-regarding-public-health-risks-associated-unapproved-peptide-products
Medically & Scientifically Reviewed By

Dr. Priyanka Goel

Scientific & Medical Content Reviewer

Information last reviewed: 9 Jul 2026

The products and information offered by Verified Peptides are intended for legitimate laboratory, analytical and scientific research applications only. Products are not for human or veterinary use, and are not therapeutic goods. The results of studies should be interpreted based on the experimental model and the limitations of the existing evidence base.

Product information and educational materials are provided only for research and informational purposes and must not be interpreted as medical advice, diagnosis or treatment.

Added to cart
View Cart Checkout